SERTAD4 and colorectal carcinoma: Having established that RNA and the protein levels of SERTAD4 are notably reduced in CRC tissues compared to normal intestinal epithelial tissues, we needed to further validate the correlation of SERTAD4 with KRAS mutations and FN infection in CRC.